Evidence map›Paper›PMID 38310124›Full record

ArticleScientific reports2024

Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases.

Xiao Yuan, Jieqiong Su, Jing Wang, Bing Dai, Yanfang Sun, Keke Zhang, Yinghua Li, Jun Chuan, Chunyan Tang, Yan Yu and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiao Yuan *Changsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Jieqiong Su *Changsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Jing WangChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Bing DaiChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Yanfang SunChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Keke ZhangChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Yinghua LiGuangzhou Kingmed Center for Clinical Laboratory, Guangzhou, Guangdong, China.
Jun ChuanGenetalks Biotech. Co., Ltd., Changsha, Hunan, China.
Chunyan TangChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China.
Yan YuChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China. hn-yuyan@kingmed.com.cn.
Qiang GongChangsha Kingmed Center for Clinical Laboratory, Lutian Road 28, Changsha, 410000, Hunan, China. hn-gongqiang@kingmed.com.cn.

Funding

The Innovation and Entrepreneurship Technology Investment Project of Hunan Province 2019GK5019The Science and Technology Planning Project of Guangzhou 202011020002
6 · The paper itself

Abstract

Phenotype-guided gene prioritizers have proved a highly efficient approach to identifying causal genes for Mendelian diseases. In our previous study, we preliminarily evaluated the performance of ten prioritizers. However, all the selected software was run based on default settings and singleton mode. With a large-scale family dataset from Deciphering Developmental Disorders (DDD) project (N = 305) and an in-house trio cohort (N = 152), the four optimal performers in our prior study including Exomiser, PhenIX, AMELIE, and LIRCIAL were further assessed through parameter optimization and/or the utilization of trio mode. The in-depth assessment revealed high diagnostic yields of the four prioritizers with refined preferences, each alone or together: (1) 83.3-91.8% of the causal genes were presented among the first ten candidates in the final ranking lists of the four tools; (2) Over 97.7% of the causal genes were successfully captured within the top 50 by either of the four software. Exomiser did best in directly hitting the target (ranking the causal gene at the very top) while LIRICAL displayed a predominant overall detection capability. Besides, cases affected by low-penetrance and high-frequency pathogenic variants were found misjudged during the automated prioritization process. The discovery of the limitations shed light on the specific directions of future enhancement for causal-gene ranking tools.

Indexed as

SoftwareHumansPhenotype

Identifiers

PMID38310124
PMCPMC10838329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.